The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Cytomegalovirus Reactivation in Critically Ill Immunocompetent Patients
Open accessAbstract
CONTEXT: Cytomegalovirus (CMV) infection is associated with adverse clinical outcomes in immunosuppressed persons, but the incidence and association of CMV reactivation with adverse outcomes in critically ill persons lacking evidence of immunosuppression have not been well defined. OBJECTIVE: To determine the association of CMV reactivation with intensive care unit (ICU) and hospital length of stay in critically ill immunocompetent persons. DESIGN, SETTING, AND PARTICIPANTS: We prospectively assessed CMV plasma DNAemia by thrice-weekly real-time polymerase chain reaction (PCR) and clinical outcomes in a cohort of 120 CMV-seropositive, immunocompetent adults admitted to 1 of 6 ICUs at 2 separate hospitals at a large US tertiary care academic medical center between 2004 and 2006. Clinical measurements were assessed by personnel blinded to CMV PCR results. Risk factors for CMV reactivation and association with hospital and ICU length of stay were assessed by multivariable logistic regression and proportional odds models. MAIN OUTCOME MEASURES: Association of CMV reactivation with prolonged hospital length of stay or death. RESULTS: The primary composite end point of continued hospitalization (n = 35) or death (n = 10) by 30 days occurred in 45 (35%) of the 120 patients. Cytomegalovirus viremia at any level occurred in 33% (39/120; 95% confidence interval [CI], 24%-41%) at a median of 12 days (range, 3-57 days) and CMV viremia greater than 1000 copies/mL occurred in 20% (24/120; 95% CI, 13%-28%) at a median of 26 days (range, 9-56 days). By logistic regression, CMV infection at any level (adjusted odds ratio [OR], 4.3; 95% CI, 1.6-11.9; P = .005) and at greater than 1000 copies/mL (adjusted OR, 13.9; 95% CI, 3.2-60; P < .001) and the average CMV area under the curve (AUC) in log(10) copies per milliliter (adjusted OR, 2.1; 95% CI, 1.3-3.2; P < .001) were independently associated with hospitalization or death by 30 days. In multivariable partial proportional odds models, both CMV 7-day moving average (OR, 5.1; 95% CI, 2.9-9.1; P < .001) and CMV AUC (OR, 3.2; 95% CI, 2.1-4.7; P < .001) were independently associated with a hospital length of stay of at least 14 days. CONCLUSIONS: These preliminary findings suggest that reactivation of CMV occurs frequently in critically ill immunocompetent patients and is associated with prolonged hospitalization or death. A controlled trial of CMV prophylaxis in this setting is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Baker, S. P., O’Neill, B., Haddon, W. F., & Long, W. B. (1974) · PubMed · Cited by 7,946
APACHE II: a severity of disease classification system.
Knaus, W. A., Draper, E. S., Wagner, D. P., & Zimmerman, J. E. (1985) · PubMed · Cited by 6,034
Infection in Organ-Transplant Recipients
Fishman, J. A., & Rubin, R. H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806113382407 · Cited by 1,622
APACHE II-A Severity of Disease Classification System
Gall, J.-R. L., Loirat, P., & Alpcrovitch, A. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00027 · Cited by 1,236
Clinical and economic consequences of ventilator-associated pneumonia: A systematic review
Safdar, N., Dezfulian, C., Collard, H. R., & Saint, S. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000181731.53912.d9 · Cited by 1,086
Pittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Partial Proportional Odds Models for Ordinal Response Variables
Peterson, B., & Harrell, F. E. (1990) · Applied Statistics · doi:10.2307/2347760 · Cited by 813
Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation
Lowance, D., Neumayer, H.-H., Legendre, C. M., Squifflet, J.-P., Kovarik, J., Brennan, P. J., Norman, D., Mendez, R., Keating, M. R., Coggon, G. L., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905133401903 · Cited by 712
Kalil, A. C., Levitsky, J., Lyden, E., Stoner, J., & Freifeld, A. G. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-12-200512200-00005 · Cited by 389
Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia.
Chastre, J., Fagon, J. Y., Bornet-Lecso, M., Calvat, S., Dombret, M. C., al Khani, R., Basset, F., & Gibert, C. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.1.7599829 · Cited by 363
Hodson, E. M., Jones, C. A., Webster, A. C., Strippoli, G. F., Barclay, P. G., Kable, K., Vimalachandra, D., & Craig, J. C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66553-1 · Cited by 350
George, M. J., Snydman, D. R., Werner, B. G., Griffith, J., Falagas, M. E., Dougherty, N. N., & Rubin, R. H. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)80021-6 · Cited by 308
Valantine, H. A., Gao, S.-Z., Menon, S. G., Renlund, D. G., Hunt, S. A., Oyer, P., Stinson, E. B., Brown, B. W., Merigan, T. C., & Schroeder, J. S. (1999) · Circulation · doi:10.1161/01.cir.100.1.61 · Cited by 292
Optimization of Quantitative Detection of Cytomegalovirus DNA in Plasma by Real-Time PCR
Boeckh, M., Huang, M., Ferrenberg, J., Stevens-Ayers, T., Stensland, L., Nichols, W. G., & Corey, L. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.3.1142-1148.2004 · Cited by 260
Impact of Cytomegalovirus in Organ Transplant Recipients in the Era of Antiviral Prophylaxis
Limaye, A. P., Bakthavatsalam, R., Kim, H. W., Randolph, S. E., Halldorson, J. B., Healey, P. J., Kuhr, C. S., Levy, A. E., Perkins, J. D., Reyes, J. D., et al. (2006) · Transplantation · doi:10.1097/01.tp.0000226071.12562.1a · Cited by 240
High Incidence of Active Cytomegalovirus Infection Among Septic Patients
Kutza, A. S. T., Muhl, E., Hackstein, H., Kirchner, H., & Bein, G. (1998) · Clinical Infectious Diseases · doi:10.1086/520307 · Cited by 190
Cytomegalovirus Infection in Critically Ill Patients
Jaber, S., Chanques, G., Borry, J., Souche, B., Verdier, R., Perrigault, P.-F., & Eledjam, J.-J. (2005) · Chest · doi:10.1378/chest.127.1.233 · Cited by 188
Human cytomegalovirus infections in nonimmunosuppressed critically ill patients
Heininger, A., Jahn, G., Engel, C., Notheisen, T., Unertl, K., & Hamprecht, K. (2001) · Critical Care Medicine · doi:10.1097/00003246-200103000-00012 · Cited by 172
Cook, C. H., Trgovcich, J., Zimmerman, P. D., Zhang, Y., & Sedmak, D. D. (2006) · Journal of Virology · doi:10.1128/jvi.00216-06 · Cited by 162
Small, L. N., Lau, J., & Snydman, D. R. (2006) · Clinical Infectious Diseases · doi:10.1086/507337 · Cited by 150
Beyersmann, J., Gastmeier, P., Grundmann, H., Bärwolff, S., Geffers, C., Behnke, M., Rüden, H., & Schumacher, M. C. (2006) · Infection Control and Hospital Epidemiology · doi:10.1086/503375 · Cited by 145
Strippoli, G. F., Hodson, E. M., Jones, C., & Craig, J. C. (2006) · Transplantation · doi:10.1097/01.tp.0000183970.71366.da · Cited by 132
Occult herpes family viral infections are endemic in critically ill surgical patients
Cook, C. H., Martin, L. C., Yenchar, J. K., Lahm, M. C., McGuinness, B. J., Davies, E. A., & Ferguson, R. M. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000070222.11325.c4 · Cited by 128
Active Cytomegalovirus Infection in Patients with Septic Shock
von Müller, L., Klemm, A., Weiß, M., Schneider, M., Suger-Wiedeck, H., Durmus, N., Hampl, W., & Mertens, T. (2006) · Emerging infectious diseases · doi:10.3201/eid1210.060411 · Cited by 115
Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice*
Cook, C. H., Zhang, Y., Sedmak, D. D., Martin, L. C., Jewell, S. D., & Ferguson, R. M. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000201876.11059.05 · Cited by 107
Occult herpes family viruses may increase mortality in critically ill surgical patients
Cook, C. H., Yenchar, J. K., Kraner, T. O., Davies, E. A., & Ferguson, R. M. (1998) · The American Journal of Surgery · doi:10.1016/s0002-9610(98)00205-0 · Cited by 107
Cook, C. H., Zhang, Y., McGuinness, B. J., Lahm, M. C., Sedmak, D. D., & Ferguson, R. M. (2002) · The Journal of Infectious Diseases · doi:10.1086/340508 · Cited by 79
Determinants of Cardiovascular Mortality After Renal Transplantation: A Role For Cytomegalovirus?
Kalil, R. S., Hudson, S. L., & Gaston, R. S. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.30114.x · Cited by 37
Cited by
Severe Sepsis and Septic Shock
Angus, D. C., & van der Poll, T. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208623 · Cited by 3,961
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · Nature Reviews Immunology · doi:10.1038/nri3552 · Cited by 2,772
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
Boomer, J. S., To, K., Chang, K. C., Takasu, O., Osborne, D. F., Walton, A. H., Bricker, T. L., Jarman, S. D., Kreisel, D., Krupnick, A. S., et al. (2011) · JAMA · doi:10.1001/jama.2011.1829 · Cited by 1,781
Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70001-x · Cited by 1,442
Age-dependent dysregulation of innate immunity
Shaw, A. C., Goldstein, D. R., & Montgomery, R. R. (2013) · Nature Reviews Immunology · doi:10.1038/nri3547 · Cited by 1,061
Metadata
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2008-07-23
- Volume
- 300
- Issue
- 4
- Pages
- 413
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1492950536
- Cited by
- 572
- References
- 30
- FWCI
- 26.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.